MedPath

Efficacy and Safety of Intraperitoneal Bupivacaine Alone or with Dexmedetomidine on Postoperative Analgesia after Laparoscopic Cholecystectomy

Not Applicable
Recruiting
Conditions
Surgery
Postoperative pain
Registration Number
PACTR201708002497386
Lead Sponsor
Ahmed Mohamed Ibrahim Ahmed
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

ASA physical status I and II of both sex and Age group18-60 years old) undergoing elective laparoscopic cholecystectomy under general anesthesia.

Exclusion Criteria

Patients with hypersensitivity or intolerance to the study drugs, severe renal dysfunction, severe hepatic dysfunction where metabolism of the drug may be greatly altered, severe cardiac disease with low cardiac output or conduction abnormalities as heart block, history of psychiatric illness, leaving intra abdominal drain at end of surgery and intraoperative change from laparoscopic to open surgery will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
¿Postoperative visual analogue score will be recorded immediately postoperative and at 1, 6, 12 and 24 hours;¿First time to request analgesia in minutes
Secondary Outcome Measures
NameTimeMethod
¿Postoperative 24 hours analgesic requirement (pethidine) in mg.
© Copyright 2025. All Rights Reserved by MedPath